Atlas Venture’s Post

In a recent GlobeSt story about the life sciences sector, I was able to give some insight on the expansion of life sciences investments and emerging markets. Life sciences investments are expanding beyond Boston and San Diego into secondary markets like Florida. Site selection factors include proximity to universities, existing operations, and infrastructure considerations. Companies are also exploring specialized development, such as cGMP production and vivarium spaces. The onshore production need, emphasized during the pandemic, remains crucial. Emerging markets are witnessing significant growth in the bioscience healthcare workforce, attracting startups and established companies. The industry is diversifying geographically to seize various opportunities and support future advancements. https://lnkd.in/eba-nFxY #LifeSciences #ResearchCollaboration #WorkforceDevelopment #DevelopmentTrends #BioResearch 

💭Interesting article discussing the benefits of biotech research clusters in the US. They seem to be thriving in Boston, San Diego and San Francisco. Texas is being pinned as the next cluster location in 3-5 years!! 👀 Key Benefits: 1. Innovation & Collaboration 2. Talent Attraction 3. Infrastructure & Resources 4. Network Opportunities What do you think? #biotech #clusters #innovation

🚀 Join us for an exciting presentation and panel discussion exploring the dynamic biotech ecosystem in San Diego! 📅 Tuesday, June 18th 🕓 4:30 - 7:00 PM 📍The Alexandria at Torrey Pines, 10996 Torreyana Rd, San Diego, CA 92121 🔬 Our panel will feature four distinguished members from the local venture capital and institutional investment community, offering their insights into the San Diego life sciences industry. We will delve into the landscape of the industry, how companies secure funding, and how investors and advisors can tap into this pipeline of opportunities. 💡 Topics include: What do fund managers look for when evaluating prospective investments? What are the various funding stages of a typical biotech company? Key questions investors should ask at each stage of funding. The influential roles of leading academic and research institutions. How "Big Pharma" views and collaborates with smaller companies to enhance their therapeutic pipelines. Why San Diego is uniquely primed for life sciences companies. 🎤 Don’t miss out on this opportunity to learn from leaders in one of San Diego’s fastest-growing industries! Last call to register - https://cvent.me/mV9qoB

Boston, the San Francisco Bay Area and San Diego are once again the top markets for life sciences commercial real estate in the U.S., with plenty of opportunities for growth as biotech readies for a comeback, according to a new report.

Boston, the San Francisco Bay Area and San Diego are once again the top markets for life sciences commercial real estate in the U.S., with plenty of opportunities for growth as biotech readies for a comeback, according to a new report.

Had an amazing time at Bisnow Mid-Atlantic Life Sciences & Biotech Summit. Each of the panelists provided valuable insights as to the currrent state of the life sciences space as it relates to our regions’ talent pool (among the largest in the country). I particularly enjoyed the discussion around the evolution of this ecosystem to build and sustain a growth trajectory to become an internationally recognized hub to attract and retain top talent in this field. We are fostering some of the brightest minds coming out of the countries top educational institutions located right in our backyard and it’s our job to properly align them with local companies that can provide them a fruitful and vibrant work/life balance in order to keep them here. My buddy Justin Gore with JLL did a fantastic job moderating a panel of experts in the brokerage and design field. It was fascinating to hear about pros and cons on the construction of brand new space vs. existing asset conversions. So many variables to consider and it’s definitely not a “one size fits all” model. JK Moving Services is the DC Metro’s premier lab and critical environment relocation experts. Our understanding of what’s at stake from an R&D and manufacturing standpoint as well as how to properly handle the physical assets during any transition allows us to provide a seamless and stress-free experience for our clients. If you have any needs (no matter how big or small) please reach out! #lifescience #biotech #pharma #criticalenvironments #whatmattersmost #jkmoving

Unveiling Opportunity Austin’s Regional Life Sciences Report, conducted by McKinsey & Company: Austin’s unique innovation ecosystem gives us a competitive edge in life sciences. With nearly 300 companies, $440M in VC funding, and 4M sq. ft. of specialized space, the Austin region is poised to become a globally recognized life sciences hub. Learn more about life sciences in Austin and download the report: https://hubs.la/Q02CK9hK0

What drives dynamic innovation communities? Where does research and commercialization converge? How does capital contribute to creating these innovation clusters? And, why is bench to bedside so important? Come join us this Thursday for an engaging conversation at the Revista Life Science Investment Forum where I’ll be joined by these esteemed experts: Chris Schad of Mayo Clinic and the Destination Medical Center, Rosalio Arellanes of Wexford Science and Technology, and Chris Lashmet with Berkadia, as we tackle these questions and more in developing the ecosystem for innovation and science. #RevistaForums24

The U.S. life sciences real estate market faces multiple challenges this year, though the sector’s resilience is underscored by factors including increased federal funding, a growing pipeline of approved drugs and more corporate spending on research and development, according to CBRE’s 2024 U.S. Life Sciences Outlook. According to CBRE, in 2024, 21.3 million sf of life science space will be completed in the 13 largest U.S. markets. Most of the construction scheduled for completion this year, 79%, is in the three largest biotech hubs: Boston, the San Francisco Bay Area, and San Diego. The potential for a high vacancy rate in those areas is greatest, while supply and demand is expected to remain more balanced in the 10 other primary markets (Average vacancy in the 13 markets stood at 10.6% as of the third quarter of 2023). More from CBRE: https://ow.ly/kp0130sBMIr #sciencemarket #lifescience #CRE #realestate

Life sciences companies are returning to dealmaking amid cost and revenue pressures – how will they find the right deals to secure value? Check out this article, “How Life Sciences Can Make The Right Deals In A Time of Change,” authored by my colleague Subin Baral. #buildingabetterworkingworld #innovation